213 related articles for article (PubMed ID: 36644636)
21. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
22. Could Ultrasound-Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer?
Qiu X; Jiang Y; Zhao Q; Yan C; Huang M; Jiang T
J Ultrasound Med; 2020 Oct; 39(10):1897-1905. PubMed ID: 32329142
[TBL] [Abstract][Full Text] [Related]
23. Dedicated Axillary MRI-Based Radiomics Analysis for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer.
Samiei S; Granzier RWY; Ibrahim A; Primakov S; Lobbes MBI; Beets-Tan RGH; van Nijnatten TJA; Engelen SME; Woodruff HC; Smidt ML
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673071
[TBL] [Abstract][Full Text] [Related]
24. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer.
Liu M; Mao N; Ma H; Dong J; Zhang K; Che K; Duan S; Zhang X; Shi Y; Xie H
Cancer Imaging; 2020 Sep; 20(1):65. PubMed ID: 32933585
[TBL] [Abstract][Full Text] [Related]
26. Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach.
Liu Q; Li J; Xu L; Wang J; Zeng Z; Fu J; Huang X; Chu Y; Wang J; Zhang HY; Zeng F
Front Oncol; 2021; 11():620945. PubMed ID: 33996544
[No Abstract] [Full Text] [Related]
27. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer.
Zhang X; Yang Z; Cui W; Zheng C; Li H; Li Y; Lu L; Mao J; Zeng W; Yang X; Zheng J; Shen J
Eur Radiol; 2021 Aug; 31(8):5924-5939. PubMed ID: 33569620
[TBL] [Abstract][Full Text] [Related]
28. Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.
Luo HB; Liu YY; Wang CH; Qing HM; Wang M; Zhang X; Chen XY; Xu GH; Zhou P; Ren J
PLoS One; 2021; 16(3):e0247074. PubMed ID: 33647031
[TBL] [Abstract][Full Text] [Related]
29. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
[TBL] [Abstract][Full Text] [Related]
30. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
31. The Diagnostic Performance of Machine Learning-Based Radiomics of DCE-MRI in Predicting Axillary Lymph Node Metastasis in Breast Cancer: A Meta-Analysis.
Zhang J; Li L; Zhe X; Tang M; Zhang X; Lei X; Zhang L
Front Oncol; 2022; 12():799209. PubMed ID: 35186739
[TBL] [Abstract][Full Text] [Related]
32. Contrast-Enhanced Spectral Mammography-Based Prediction of Non-Sentinel Lymph Node Metastasis and Axillary Tumor Burden in Patients With Breast Cancer.
Wu X; Guo Y; Sa Y; Song Y; Li X; Lv Y; Xing D; Sun Y; Cong Y; Yu H; Jiang W
Front Oncol; 2022; 12():823897. PubMed ID: 35615151
[TBL] [Abstract][Full Text] [Related]
33. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using CNN Based on Multiparametric MRI.
Wang Z; Sun H; Li J; Chen J; Meng F; Li H; Han L; Zhou S; Yu T
J Magn Reson Imaging; 2022 Sep; 56(3):700-709. PubMed ID: 35108415
[TBL] [Abstract][Full Text] [Related]
34. Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.
Ming W; Zhu Y; Bai Y; Gu W; Li F; Hu Z; Xia T; Dai Z; Yu X; Li H; Gu Y; Yuan S; Zhang R; Li H; Zhu W; Ding J; Sun X; Liu Y; Liu H; Liu X
Front Oncol; 2022; 12():943326. PubMed ID: 35965527
[TBL] [Abstract][Full Text] [Related]
35. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
Zhu J; Xu WG; Xiao H; Zhou Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
[TBL] [Abstract][Full Text] [Related]
36. Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Tan H; Wu Y; Bao F; Zhou J; Wan J; Tian J; Lin Y; Wang M
Br J Radiol; 2020 Jul; 93(1111):20191019. PubMed ID: 32401540
[TBL] [Abstract][Full Text] [Related]
37. A nomogram based on radiomics signature and deep-learning signature for preoperative prediction of axillary lymph node metastasis in breast cancer.
Wang D; Hu Y; Zhan C; Zhang Q; Wu Y; Ai T
Front Oncol; 2022; 12():940655. PubMed ID: 36338691
[TBL] [Abstract][Full Text] [Related]
38. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study.
Mao N; Yin P; Li Q; Wang Q; Liu M; Ma H; Dong J; Che K; Wang Z; Duan S; Zhang X; Hong N; Xie H
Eur Radiol; 2020 Dec; 30(12):6732-6739. PubMed ID: 32607630
[TBL] [Abstract][Full Text] [Related]
39. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
40. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).
Peng G; Zhan Y; Wu Y; Zeng C; Wang S; Guo L; Liu W; Luo L; Wang R; Huang K; Huang B; Chen J; Chen C
Front Oncol; 2022; 12():988859. PubMed ID: 36387160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
